Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Metastatic Cancer Treatment Market Size Growth Rate by Type (2014-2025) 1.4.2 Chemotherapy 1.4.3 Radiation Therapy 1.4.4 Biologic Targeted Therapy 1.4.5 Breast Surgery 1.4.6 Hormone Therapy 1.5 Market by Application 1.5.1 Global Metastatic Cancer Treatment Market Share by Application (2014-2025) 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Metastatic Cancer Treatment Market Size 2.2 Metastatic Cancer Treatment Growth Trends by Regions 2.2.1 Metastatic Cancer Treatment Market Size by Regions (2014-2025) 2.2.2 Metastatic Cancer Treatment Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Metastatic Cancer Treatment Market Size by Manufacturers 3.1.1 Global Metastatic Cancer Treatment Revenue by Manufacturers (2014-2018) 3.1.2 Global Metastatic Cancer Treatment Revenue Market Share by Manufacturers (2014-2018) 3.1.3 Global Metastatic Cancer Treatment Market Concentration Ratio (CR5 and HHI) 3.2 Metastatic Cancer Treatment Key Players Head office and Area Served 3.3 Key Players Metastatic Cancer Treatment Product/Solution/Service 3.4 Date of Enter into Metastatic Cancer Treatment Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Metastatic Cancer Treatment Market Size by Type (2014-2019) 4.2 Global Metastatic Cancer Treatment Market Size by Application (2014-2019) 5 United States 5.1 United States Metastatic Cancer Treatment Market Size (2014-2019) 5.2 Metastatic Cancer Treatment Key Players in United States 5.3 United States Metastatic Cancer Treatment Market Size by Type 5.4 United States Metastatic Cancer Treatment Market Size by Application 6 Europe 6.1 Europe Metastatic Cancer Treatment Market Size (2014-2019) 6.2 Metastatic Cancer Treatment Key Players in Europe 6.3 Europe Metastatic Cancer Treatment Market Size by Type 6.4 Europe Metastatic Cancer Treatment Market Size by Application 7 China 7.1 China Metastatic Cancer Treatment Market Size (2014-2019) 7.2 Metastatic Cancer Treatment Key Players in China 7.3 China Metastatic Cancer Treatment Market Size by Type 7.4 China Metastatic Cancer Treatment Market Size by Application 8 Japan 8.1 Japan Metastatic Cancer Treatment Market Size (2014-2019) 8.2 Metastatic Cancer Treatment Key Players in Japan 8.3 Japan Metastatic Cancer Treatment Market Size by Type 8.4 Japan Metastatic Cancer Treatment Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Metastatic Cancer Treatment Market Size (2014-2019) 9.2 Metastatic Cancer Treatment Key Players in Southeast Asia 9.3 Southeast Asia Metastatic Cancer Treatment Market Size by Type 9.4 Southeast Asia Metastatic Cancer Treatment Market Size by Application 10 India 10.1 India Metastatic Cancer Treatment Market Size (2014-2019) 10.2 Metastatic Cancer Treatment Key Players in India 10.3 India Metastatic Cancer Treatment Market Size by Type 10.4 India Metastatic Cancer Treatment Market Size by Application 11 Central & South America 11.1 Central & South America Metastatic Cancer Treatment Market Size (2014-2019) 11.2 Metastatic Cancer Treatment Key Players in Central & South America 11.3 Central & South America Metastatic Cancer Treatment Market Size by Type 11.4 Central & South America Metastatic Cancer Treatment Market Size by Application 12 International Players Profiles 12.1 Roche 12.1.1 Roche Company Details 12.1.2 Company Description and Business Overview 12.1.3 Metastatic Cancer Treatment Introduction 12.1.4 Roche Revenue in Metastatic Cancer Treatment Business (2014-2019) 12.1.5 Roche Recent Development 12.2 Novartis 12.2.1 Novartis Company Details 12.2.2 Company Description and Business Overview 12.2.3 Metastatic Cancer Treatment Introduction 12.2.4 Novartis Revenue in Metastatic Cancer Treatment Business (2014-2019) 12.2.5 Novartis Recent Development 12.3 Merck 12.3.1 Merck Company Details 12.3.2 Company Description and Business Overview 12.3.3 Metastatic Cancer Treatment Introduction 12.3.4 Merck Revenue in Metastatic Cancer Treatment Business (2014-2019) 12.3.5 Merck Recent Development 12.4 Eli Lilly 12.4.1 Eli Lilly Company Details 12.4.2 Company Description and Business Overview 12.4.3 Metastatic Cancer Treatment Introduction 12.4.4 Eli Lilly Revenue in Metastatic Cancer Treatment Business (2014-2019) 12.4.5 Eli Lilly Recent Development 12.5 Johnson & Johnson 12.5.1 Johnson & Johnson Company Details 12.5.2 Company Description and Business Overview 12.5.3 Metastatic Cancer Treatment Introduction 12.5.4 Johnson & Johnson Revenue in Metastatic Cancer Treatment Business (2014-2019) 12.5.5 Johnson & Johnson Recent Development 12.6 Pfizer 12.6.1 Pfizer Company Details 12.6.2 Company Description and Business Overview 12.6.3 Metastatic Cancer Treatment Introduction 12.6.4 Pfizer Revenue in Metastatic Cancer Treatment Business (2014-2019) 12.6.5 Pfizer Recent Development 12.7 AstraZeneca 12.7.1 AstraZeneca Company Details 12.7.2 Company Description and Business Overview 12.7.3 Metastatic Cancer Treatment Introduction 12.7.4 AstraZeneca Revenue in Metastatic Cancer Treatment Business (2014-2019) 12.7.5 AstraZeneca Recent Development 12.8 GlaxoSmithKline 12.8.1 GlaxoSmithKline Company Details 12.8.2 Company Description and Business Overview 12.8.3 Metastatic Cancer Treatment Introduction 12.8.4 GlaxoSmithKline Revenue in Metastatic Cancer Treatment Business (2014-2019) 12.8.5 GlaxoSmithKline Recent Development 12.9 Sun Pharmaceutical 12.9.1 Sun Pharmaceutical Company Details 12.9.2 Company Description and Business Overview 12.9.3 Metastatic Cancer Treatment Introduction 12.9.4 Sun Pharmaceutical Revenue in Metastatic Cancer Treatment Business (2014-2019) 12.9.5 Sun Pharmaceutical Recent Development 12.10 Bayer 12.10.1 Bayer Company Details 12.10.2 Company Description and Business Overview 12.10.3 Metastatic Cancer Treatment Introduction 12.10.4 Bayer Revenue in Metastatic Cancer Treatment Business (2014-2019) 12.10.5 Bayer Recent Development 12.11 Gilead Sciences 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Metastatic Cancer Treatment Key Market Segments Table Key Players Metastatic Cancer Treatment Covered Table Global Metastatic Cancer Treatment Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Metastatic Cancer Treatment Market Size Market Share by Type 2014-2025 Figure Chemotherapy Figures Table Key Players of Chemotherapy Figure Radiation Therapy Figures Table Key Players of Radiation Therapy Figure Biologic Targeted Therapy Figures Table Key Players of Biologic Targeted Therapy Figure Breast Surgery Figures Table Key Players of Breast Surgery Figure Hormone Therapy Figures Table Key Players of Hormone Therapy Table Global Metastatic Cancer Treatment Market Size Growth by Application 2014-2025 (Million US$) Figure Hospitals Case Studies Figure Clinics Case Studies Figure Other Case Studies Figure Metastatic Cancer Treatment Report Years Considered Table Global Metastatic Cancer Treatment Market Size 2014-2025 (Million US$) Figure Global Metastatic Cancer Treatment Market Size and Growth Rate 2014-2025 (Million US$) Table Global Metastatic Cancer Treatment Market Size by Regions 2014-2025 (Million US$) Table Global Metastatic Cancer Treatment Market Size by Regions 2014-2019 (Million US$) Table Global Metastatic Cancer Treatment Market Share by Regions 2014-2019 Figure Global Metastatic Cancer Treatment Market Share by Regions 2014-2019 Figure Global Metastatic Cancer Treatment Market Share by Regions 2019 Table Market Top Trends Table Global Metastatic Cancer Treatment Revenue by Manufacturers (2014-2019) (Million US$) Table Global Metastatic Cancer Treatment Market Share by Manufacturers (2014-2019) Figure Global Metastatic Cancer Treatment Market Share by Manufacturers in 2018 Table Global Metastatic Cancer Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Metastatic Cancer Treatment Product/Solution/Service Table Date of Enter into Metastatic Cancer Treatment Market Table Mergers & Acquisitions, Expansion Plans Table Global Metastatic Cancer Treatment Market Size by Type (2014-2019) (Million US$) Table Global Metastatic Cancer Treatment Market Size Share by Type (2014-2019) Figure Global Metastatic Cancer Treatment Market Size Market Share by Type (2014-2019) Table Global Metastatic Cancer Treatment Market Size by Application (2014-2019) (Million US$) Table Global Metastatic Cancer Treatment Market Size Share by Application (2014-2019) Figure Global Metastatic Cancer Treatment Market Size Market Share by Application (2014-2019) Figure Global Metastatic Cancer Treatment Revenue Market Share by Application in 2018 Figure United States Metastatic Cancer Treatment Market Size 2014-2019 (Million US$) Table United States Key Players Metastatic Cancer Treatment Revenue (2018-2019) (Million US$) Table United States Key Players Metastatic Cancer Treatment Market Share (2018-2019) Table United States Metastatic Cancer Treatment Market Size by Type (2014-2019) (Million US$) Table United States Metastatic Cancer Treatment Market Share by Type (2014-2019) Table United States Metastatic Cancer Treatment Market Size by Application (2014-2019) (Million US$) Table United States Metastatic Cancer Treatment Market Share by Application (2014-2019) Figure Europe Metastatic Cancer Treatment Market Size 2014-2019 (Million US$) Table Europe Key Players Metastatic Cancer Treatment Revenue (2018-2019) (Million US$) Table Europe Key Players Metastatic Cancer Treatment Market Share (2018-2019) Table Europe Metastatic Cancer Treatment Market Size by Type (2014-2019) (Million US$) Table Europe Metastatic Cancer Treatment Market Share by Type (2014-2019) Table Europe Metastatic Cancer Treatment Market Size by Application (2014-2019) (Million US$) Table Europe Metastatic Cancer Treatment Market Share by Application (2014-2019) Figure China Metastatic Cancer Treatment Market Size 2014-2019 (Million US$) Table China Key Players Metastatic Cancer Treatment Revenue (2018-2019) (Million US$) Table China Key Players Metastatic Cancer Treatment Market Share (2018-2019) Table China Metastatic Cancer Treatment Market Size by Type (2014-20189) (Million US$) Table China Metastatic Cancer Treatment Market Share by Type (2014-2019) Table China Metastatic Cancer Treatment Market Size by Application (2014-2019) (Million US$) Table China Metastatic Cancer Treatment Market Share by Application (2014-2019) Figure Japan Metastatic Cancer Treatment Market Size 2014-2019 (Million US$) Table Japan Key Players Metastatic Cancer Treatment Revenue (2018-2019) (Million US$) Table Japan Key Players Metastatic Cancer Treatment Market Share (2018-2019) Table Japan Metastatic Cancer Treatment Market Size by Type (2014-2019) (Million US$) Table Japan Metastatic Cancer Treatment Market Share by Type (2014-2019) Table Japan Metastatic Cancer Treatment Market Size by Application (2014-2019) (Million US$) Table Japan Metastatic Cancer Treatment Market Share by Application (2014-2019) Figure Southeast Asia Metastatic Cancer Treatment Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Metastatic Cancer Treatment Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Metastatic Cancer Treatment Market Share (2018-2019) Table Southeast Asia Metastatic Cancer Treatment Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Metastatic Cancer Treatment Market Share by Type (2014-2019) Table Southeast Asia Metastatic Cancer Treatment Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Metastatic Cancer Treatment Market Share by Application (2014-2019) Figure India Metastatic Cancer Treatment Market Size 2014-2019 (Million US$) Table India Key Players Metastatic Cancer Treatment Revenue (2018-2019) (Million US$) Table India Key Players Metastatic Cancer Treatment Market Share (2018-2019) Table India Metastatic Cancer Treatment Market Size by Type (2014-2019) (Million US$) Table India Metastatic Cancer Treatment Market Share by Type (2014-2019) Table India Metastatic Cancer Treatment Market Size by Application (2014-2019) (Million US$) Table India Metastatic Cancer Treatment Market Share by Application (2014-2019) Figure Central & South America Metastatic Cancer Treatment Market Size 2014-2019 (Million US$) Table Central & South America Key Players Metastatic Cancer Treatment Revenue (2018-2019) (Million US$) Table Central & South America Key Players Metastatic Cancer Treatment Market Share (2018-2019) Table Central & South America Metastatic Cancer Treatment Market Size by Type (2014-2019) (Million US$) Table Central & South America Metastatic Cancer Treatment Market Share by Type (2014-2019) Table Central & South America Metastatic Cancer Treatment Market Size by Application (2014-2019) (Million US$) Table Central & South America Metastatic Cancer Treatment Market Share by Application (2014-2019) Table Roche Company Details Table Roche Revenue in Metastatic Cancer Treatment Business (2014-2019) (Million US$) Figure Roche Revenue Growth Rate in Metastatic Cancer Treatment Business (2014-2019) Table Roche Recent Development Table Novartis Company Details Table Novartis Revenue in Metastatic Cancer Treatment Business (2014-2019)(Million US$) Figure Novartis Revenue Growth Rate in Metastatic Cancer Treatment Business (2014-2019) Table Novartis Recent Development Table Merck Company Details Table Merck Revenue in Metastatic Cancer Treatment Business (2014-2019)(Million US$) Figure Merck Revenue Growth Rate in Metastatic Cancer Treatment Business (2014-2019) Table Merck Recent Development Table Eli Lilly Company Details Table Eli Lilly Revenue in Metastatic Cancer Treatment Business (2014-2019)(Million US$) Figure Eli Lilly Revenue Growth Rate in Metastatic Cancer Treatment Business (2014-2019) Table Eli Lilly Recent Development Table Johnson & Johnson Company Details Table Johnson & Johnson Revenue in Metastatic Cancer Treatment Business (2014-2019)(Million US$) Figure Johnson & Johnson Revenue Growth Rate in Metastatic Cancer Treatment Business (2014-2019) Table Johnson & Johnson Recent Development Table Pfizer Company Details Table Pfizer Revenue in Metastatic Cancer Treatment Business (2014-2019)(Million US$) Figure Pfizer Revenue Growth Rate in Metastatic Cancer Treatment Business (2014-2019) Table Pfizer Recent Development Table AstraZeneca Company Details Table AstraZeneca Revenue in Metastatic Cancer Treatment Business (2014-2019)(Million US$) Figure AstraZeneca Revenue Growth Rate in Metastatic Cancer Treatment Business (2014-2019) Table AstraZeneca Recent Development Table GlaxoSmithKline Company Details Table GlaxoSmithKline Revenue in Metastatic Cancer Treatment Business (2014-2019)(Million US$) Figure GlaxoSmithKline Revenue Growth Rate in Metastatic Cancer Treatment Business (2014-2019) Table GlaxoSmithKline Recent Development Table Sun Pharmaceutical Company Details Table Sun Pharmaceutical Revenue in Metastatic Cancer Treatment Business (2014-2019)(Million US$) Figure Sun Pharmaceutical Revenue Growth Rate in Metastatic Cancer Treatment Business (2014-2019) Table Sun Pharmaceutical Recent Development Table Bayer Company Details Table Bayer Revenue in Metastatic Cancer Treatment Business (2014-2019)(Million US$) Figure Bayer Revenue Growth Rate in Metastatic Cancer Treatment Business (2014-2019) Table Bayer Recent Development Table Gilead Sciences Company Details Table Global Metastatic Cancer Treatment Market Size by Regions (Million US$) 2019-2025 Figure Global Metastatic Cancer Treatment Market Size Share by Regions (2019-2025) Figure Global Metastatic Cancer Treatment Market Size Share by Regions in 2025 Figure United States Metastatic Cancer Treatment Market Size Forecast (2019-2025)(Million USD) Figure Europe Metastatic Cancer Treatment Market Size Forecast (2019-2025)(Million USD) Figure China Metastatic Cancer Treatment Market Size Forecast (2019-2025)(Million USD) Figure Japan Metastatic Cancer Treatment Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Metastatic Cancer Treatment Market Size Forecast (2019-2025)(Million USD) Figure India Metastatic Cancer Treatment Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Metastatic Cancer Treatment Market Size Forecast (2019-2025)(Million USD) Table Global Metastatic Cancer Treatment Market Size by Product (2019-2025) (Million US$) Figure Global Metastatic Cancer Treatment Market Size by Product (2019-2025) Figure Global Metastatic Cancer Treatment Market Size by Product in 2025 Table Global Metastatic Cancer Treatment Market Size by Application (2019-2025) (Million US$) Figure Global Metastatic Cancer Treatment Market Size by Application (2019-2025) Figure Global Metastatic Cancer Treatment Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Roche Novartis Merck Eli Lilly Johnson & Johnson Pfizer AstraZeneca GlaxoSmithKline Sun Pharmaceutical Bayer Gilead Sciences